Inventor · disambiguated record
Jon Gordon Selbo
Also filed as: SELBO JON · SELBO JON G · SELBO JON GORDON
15 granted patents·11 pending applications·53 citations·filing 2004–2025
91Inventor score
Top patents by PatentIndex Score
26 records- 0195US9259414B2Glycopyrrolate saltsDERMIRA INC·Filed 2015·Granted Feb 16, 2016·8 cites·21 claims
- 0295US9006462B2Glycopyrrolate saltsDERMIRA INC·Filed 2014·Granted Apr 14, 2015·13 cites·24 claims
- 0387US10004717B2Glycopyrrolate saltsDERMIRA INC·Filed 2017·Granted Jun 26, 2018·5 cites·31 claims
- 0486US9610278B2Glycopyrrolate saltsDERMIRA INC·Filed 2016·Granted Apr 4, 2017·4 cites·33 claims
- 0583US9737610B2Formulations of rifaximin and uses thereofSELBO JON·Filed 2014·Granted Aug 22, 2017·9 cites·15 claims
- 0682US9951041B2Crystalline C21H22Cl2N4O2 malonateBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Apr 24, 2018·3 cites·11 claims
- 0782US9670177B2Crystalline C21H22Cl2N4O2 malonateBIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jun 6, 2017·3 cites·22 claims
- 0878US10548875B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Feb 4, 2020·1 cites·27 claims
- 0978US8933088B2Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamidePHARMACIA & UPJOHN CO LLC·Filed 2012·Granted Jan 13, 2015·3 cites·16 claims
- 1077US10543192B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Jan 28, 2020·1 cites·41 claims
- 1176US2025186395A1Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2025·Application pending·0 cites
- 1272US11291652B2Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2020·Granted Apr 5, 2022·0 cites·17 claims
- 1372US11291651B2Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2020·Granted Apr 5, 2022·0 cites·23 claims
- 1470US8324230B2Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl)oxy]-6-oxopyrimidin-1(6H)-Yl]-N-(2-hydroxyethyl)-4-methylbenzamideSELBO JON G·Filed 2005·Granted Dec 4, 2012·2 cites·12 claims
- 1565US2020397904A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1661US8097733B2Pyrazole derivatives as 5-LO-inhibitorsALVIRA EDGARDO·Filed 2008·Granted Jan 17, 2012·1 cites·5 claims
- 1758US2022233500A1Glycopyrrolate saltsJOURNEY MEDICAL CORP·Filed 2022·Application pending·0 cites
- 1855US2017333562A1Formulations of rifaximin and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 1953US2023212193A1Crystalline ret inhibitorLOXO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 2053US2023183266A1Crystalline forms of ret inhibitor and preparation thereofLOXO ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 2149US2012077835A1Formulations of rifaximin and uses thereofSELBO JON·Filed 2011·Application pending·0 cites
- 2246US2005165047A1Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereofPFIZER·Filed 2004·Application pending·0 cites
- 2344US10813938B2Polymorphs of cocrystals of epigallocatechin gallate and caffeineAMRI SSCI LLC·Filed 2016·Granted Oct 27, 2020·0 cites·8 claims
- 2443US2005059698A1Quinuclidines-substituted-multi-cyclic-heteroaryls for treatment of diseasePFIZER·Filed 2004·Application pending·0 cites
- 2542US2014045724A1Formulation screening methods, apparatuses for performing such methods and formulations formed by such methodsSELBO JON·Filed 2013·Application pending·0 cites
- 2640US2020323815A1Amorphous dispersions of epigallocatechin gallateAMRI SSCI LLC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →